Novartis oncology CEO makes hasty exit

Dec 20, 2018

Just 11 months after taking on the role, Novartis oncology chief Liz Barrett said she is leaving to become chief executive of a U.S. biotech company.

Barrett will be replaced by Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company. Schaffert is a long-time Novartis exec.

Barrett cited challenges in moving her family to Basel, Novartis’s headquarters, as the reason for her departure.

Read the press statement

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments